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Objectives: We have previously shown that the angio-
tensin converting enzyme inhibitor, ramipril, improved
walking distance and reduced arterial stiffness in patients
with intermittent claudication. In this analysis on the
same cohort of patients, we investigated whether ramipril’s
ability to improve walking distance is dependent on its
ability to reduce arterial stiffness.
Methods: 33 patients (25 males; mean age, 65 6 7.8)
with intermittent claudication were randomised to receive
ramipril (n ¼ 14) or placebo (n ¼ 19) for 24 weeks in
a double-blind fashion. Walking distance was assessed using
a standard treadmill test (1.6 mph at 10% incline) and arte-
rial stiffness indices were assessed using the SphygmoCor
device.
Results: After 24 weeks, ramipril improved maximum
treadmill walking distance; adjusted mean change differ-
ence (95% conﬁdence interval); by 130.5 metres (61.8
metres to 199.2 metres) longer than placebo (P ¼ .001)
and improved treadmill intermittent claudication distance
by 121.9 metres (55.9 metres to 187.8 metres) longer
than placebo (P ¼ .001). Ramipril reduced carotid femoral
pulse wave velocity (PWVcf) by 1.47 m/s (2.4 m/s to
0.57 m/s) compared to placebo (P ¼ .002) and reduced
augmentation index (AIx) by 10.8% (14.1% to 7.5%)
compared to placebo (P < .001). Changes in walking
distance from baseline showed signiﬁcant inverse correla-
tions with changes in indices of arterial stiffness (PWVcf,
r ¼ .43, P ¼ .021; AIx, r ¼ .50, P ¼ .006; AIx adjusted
to 75 beats/minute, r ¼.50, P¼ .006; central pulse pres-
sure, r ¼ .45, P ¼ .039). Correlations remained signiﬁ-
cant after adjusting for heart rate and mean arterial pressure.
Conclusions: Ramipril improves walking distance in
patients with intermittent claudication. This improvement
is partly due to ramipril’s ability to reduce arterial stiffness.
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Objectives: To compare the incidence of deep groin
wound infections between patients having peripheral arte-
rial disease (PAD)-related operations with standard groin
incision (SGI) vs those having exposure of the femoral
vessels via an approach lateral to sartorius muscle (LSM).
Methods: Consecutive patients (n ¼ 604) who under-
went PAD-related operations were matched on propensity
score (PS) calculated as their probability to have either the
SGI or the LSM approach on the basis of operative charac-
teristics, demographics and comorbidities. Primary end-
point was the incidence of deep groin wound infections.
Single level random effects logistic and Poisson regressions
were performed to analyze outcomes.
Results: After PS matching the groups were well-
balanced on all major covariates except for that of groin
reoperation; therefore, the ﬁnal regression models were
all adjusted for this predictor. The incidence of deep groin
wound infection was lower in the LSM group (2 vs 6.3%;
OR, 0.1; P ¼ .016). An interaction term between LSM
approach and reoperation approached statistical signiﬁ-
cance (P ¼ .07) and individual interaction component anal-
ysis indicated that the beneﬁcial effect of the LSM approach
was mainly in the patients undergoing groin reoperations.
Superﬁcial infections (OR, 0.83; P ¼ .88), intra-operative
blood loss (median, 275 vs 350 cc; IRR, 1.04; P ¼ .75),
operative time (median, 4.6 vs 4.9 hours; IRR, 1.01; P ¼
.875), and incidence of perioperative death and MI (OR,
1; P ¼ .99) were similar between the SGI and LSM groups
respectively. Postoperative length of stay (median, 6 vs 8
days; IRR, 1.3; P ¼ .052) was slightly higher in the LSM
group.
Conclusions: Patients having femoral vessel exposure
via a lateral to sartorius muscle approach have a substantially
lower risk of deep groin infections, particularly if under-
going reoperation.
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Objectives: Major Lower Extremity (MLE) amputa-
tion is a profound change in a patient’s life. We seek to
determine the role of social integration in outcomes after
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including patients from the US and Tanzania (TNZ).
Methods: MLE amputees were recruited from US and
TNZ sites in a prospective study. Data collected included
demographic, social integration (CHART), walking func-
tion (Six Minute Walk Test) and QoL (EQ5D). c2 and
ANOVA tests were used to assess association between social
integration and outcomes. Multivariable logistic regression
analysis, was performed to assess the role of social context.
Results: Of the 90 enrolled patients, 50 (56%) were
from the US, 58 (64%) were male, with a mean age of
64.4 years. Patients with high social integration had a trend
toward improved function deﬁned by a score of 171 meters
or better (36% v 66% v 74%; P ¼ .055) and signiﬁcantly
higher mean EQ5D scores (0.65 v 0.70 v 0.79; P ¼
.021). Findings were more dramatic in the US sub-group
for both function (17% v 38% v 74%; P ¼ .008) and
QoL (0.52 v 0.58 v 0.79; P ¼ .001). In a multivariate anal-
ysis, the TNZ site was not associated with less favorable
function (P ¼ .783) or QoL (P ¼ .364).
Conclusions: In the US population, increased social
integration is associated with both improved function and
quality of life outcomes among amputees. This effect is
attenuated in TNZ, likely due to differences in social
context. Steps should be taken to identify and aid amputees
with poor social integration in the US and factors associ-
ated with low function elsewhere.Fig.Author Disclosures: D. M. Crandell: Nothing to
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Objectives: While many vascular surgeons follow the
algorithm of postoperative bypass vascular evaluation
including non-invasive ﬂow studies (NIFS) and bypass graft
duplex (BGD) at 1, 3, 6 months and annually thereafter,
the data surrounding this recommendation is low. It has
been shown that routine BGD scanning following autoge-
nous lower extremity bypass has not proven to be cost-
effective. The TASC II document recommends a biannual
assessment of exercise NIFS for 2 years postoperatively as
level C evidence. Superﬁcial Femoral Artery (SFA) Percuta-
neous Transluminal Angioplasty/Stent (PTA/S) trials have
required similar schedules of postprocedure evaluation. We
chose to evaluate the beneﬁt of postprocedure imaging.
Methods: We undertook a retrospective review of
a prospective database looking at SFA intervention. The
number of follow up visits, frequency of changes in exam,
changes in postprocedure NIFS and BGD were analyzed.
Results: 104 patients had SFA interventions (46 PTA,
46 PTA/stent, 8 atherectomy, 4 PTA/lysis). Initial studies
(NIFS and/or BGD) within 1-7 weeks showed a change
(ABI < .7 and/or 4:1 peak systolic velocity ratio) in
3.1% of cases, at 3 months an additional 41% showed
change (RR > 1.0; P < .05); at 6 months only an addi-
tional 8% showed change (RR < 1.0; P > 0.05). Kaplan
Meier analysis revealed a lack of signiﬁcance at the 1 year
mark and beyond due decreased follow up.
Conclusions: Of the 547 postprocedure perfusion
assays performed in these 104 patients the statistically
signiﬁcant interval appears to be at the 3 month post-
procedure visit. While the initial study acts as a baseline
the utility of further testing does not appear to add signif-
icant additional information on a cohort basis. Like algo-
rithms for distal bypass there did appear to be better
correlation when coupled with return of symptoms and
or change in physical exam.
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Objectives: Despite patent bypass grafts, some
patients receive major amputations (MA). We analyzed
the frequency and predictive factors leading to MA in the
presence of patent lower extremity bypass grafts (LEB).
Methods: Data from PREVENT III, a large prospec-
tive randomized trial of 1404 patients who underwent LEB
for critical limb ischemia (CLI) was queried for outcomes.
The primary endpoint was MA with patent (PMA) or
